ad image

Collaboration

1 / 8
Three Decades of Collaboration: Evolution from Basic Partnerships to Complex Open-Innovation Models
Collaboration

Three Decades of Collaboration: Evolution from Basic Partnerships to Complex Open-Innovation Models

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-25-30-14Mar 03, 2025
How Today’s Pharmaceutical Industry is Transforming to Support the Medicines of the Future
Future Medicines

How Today’s Pharmaceutical Industry is Transforming to Support the Medicines of the Future

Tonia Becker; RECONNEX 365

Nice Insight

PAO-02-25-CL-04Feb 06, 2025
Cryoport
Announcement

Moffitt Cancer Center and Cryoport Announce Strategic Collaboration

Cryoport

PR-01-25-NI-15Jan 16, 2025
Nona Biosciences
Announcement

Nona Biosciences Announces Update on Its Collaborator DualityBio's Antibody-Drug Conjugate (ADC) Collaboration with BeiGene

Nona Biosciences

PR-01-25-NI-02Jan 03, 2025
How Synergistic Collaborations Between Outsourcing Partners Can Accelerate Clinical Success
The PHASE Platform

How Synergistic Collaborations Between Outsourcing Partners Can Accelerate Clinical Success

Wheeler Bio

PAO-05-24-CL-01May 08, 2024
An Adaptive Ecosystem of Solutions: Evolving Clinical Trials in a Decentralized World
Decentralized Clinical Trials

An Adaptive Ecosystem of Solutions: Evolving Clinical Trials in a Decentralized World

Richie Pfeiffer

PPD, part of Thermo Fisher Scientific

PAO-12-23-CL-08Jan 17, 2024
Who is Using FAIR Data in Life Sciences R&D Today?
Data Management

Who is Using FAIR Data in Life Sciences R&D Today?

Christian Olsen

Dotmatics

PAO-09-23-CL-05Sep 11, 2023
Embracing FAIR Data on the Path to AI-Readiness
Data Management

Embracing FAIR Data on the Path to AI-Readiness

Christian Olsen

Dotmatics

PAO-09-23-CL-03Sep 01, 2023
100 Years Young: How Science, Collaboration, and Innovation are Driving Corning’s Future
History of Innovation

100 Years Young: How Science, Collaboration, and Innovation are Driving Corning’s Future

John Yoshi Shyu, Ph.D.; John M. Tobin IV

Corning Life Sciences

PAO-05-23-CL-08May 30, 2023
AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology Targets
Collaboration

AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology Targets

Anima Biotech Inc.

PR-M01-23-01-166Jan 10, 2023
Integrating Experimental Data and Artificial Intelligence to Accelerate Drug Discovery
Computational Drug Design

Integrating Experimental Data and Artificial Intelligence to Accelerate Drug Discovery

Ronald Dorenbos, Ph.D.; Guido Lanza

Charles River Laboratories

PAO-11-022-CL-11-180Dec 07, 2022
Advancing Extrusion-Based 3D Printing for Drug Production
3D Printing

Advancing Extrusion-Based 3D Printing for Drug Production

Thomas Kipping, Ph.D.; Xianghao Zuo, Ph.D.

MilliporeSigma

PAO-11-022-CL-14Nov 29, 2022
CCRM
iPSCs

Resolution Therapeutics and CCRM Sign Collaboration Agreement to Develop and Scale Up Manufacturing for Induced Pluripotent Stem Cell (iPSC)-Derived Macrophage Cell Therapies

CCRM

PR-M11-22-04Nov 07, 2022
AGC Biologics
Cell Therapy Manufacturing

RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies

AGC Biologics

PR-M08-22-03Aug 16, 2022
IDT Biologika
Scale-Up Collaboration

IDT Biologika Collaborates with Exothera to Push Forward the Scale-Up of Viral Vaccines

IDT Biologika

PR-M03-22-01Mar 01, 2022
Quris
Option Agreement

Merck KGaA, Darmstadt, Germany, Enters Into Option Agreement With Quris on Its BioAI Platform for Clinical Safety Prediction

Quris

PR-M02-22-08Feb 09, 2022
IDT Biologika
Collaboration

Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001

IDT Biologika

PR-M12-21-02Dec 15, 2021
Collaboration in Action: New Milestones Efficiency and Simplifying the Complexities of Drug Development
Collaboration

Collaboration in Action: New Milestones Efficiency and Simplifying the Complexities of Drug Development

Peter Soelkner

Vetter Pharma International GmbH

PAO-06-21-CL-02-954Jun 09, 2021
The COVID-19 Vaccine Journey Continues
COVID-19 Vaccines

The COVID-19 Vaccine Journey Continues

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-05-21-NI-02May 13, 2021
Tempus
Collaboration

Tempus Announces Sequencing and Computational Biology Collaboration with Kronos Bio to Support the Development of CDK9 Inhibitor KB-0742

Tempus

PR-M11-20-042Mar 09, 2021
1 / 8